Follow The Filings

JSPR Jasper Therapeutics

Jasper Therapeutics earnings company data as of 4:47 AM ET 10/22

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — -0.10 —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
DEF 14A PROXY STATEMENT
8-K 8.01,9.01
8-K 8.01,9.01
8-K 5.07
8-K/A 9.01
8-K/A 9.01
8-K 5.02
DEF 14A PROXY STATEMENT
8-K 1.01
SCHEDULE 13G —
10-Q QUARTERLY REPORT
8-K 2.02,9.01
8-K 5.07
8-K 8.01
SCHEDULE 13D/A —
8-K 1.01,2.01,3.02,5.02,5.03,7.01,9.01
8-K 7.01,9.01
SCHEDULE 13G/A —
DEF 14A PROXY STATEMENT
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 3.01
8-K 7.01,9.01
8-K 5.02,9.01
8-K 2.02,9.01
10-Q QUARTERLY REPORT

Insider forms

Forms 3, 4 and 5 from EDGAR, 1 row shown

Filed Form Detail Links
4 Period Jul 31, 2026 (5 forms)

2 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.